Literature DB >> 29096354

Notch signaling pathway dampens tumor-infiltrating CD8+ T cells activity in patients with colorectal carcinoma.

Weifeng Yu1, Yanjun Wang2, Peng Guo3.   

Abstract

CD8+ T cells play critical role in controlling the metastasis and prognosis of cancer. Controversy remains as to the contribution of Notch signaling pathway in modulation of CD8+ T cells activity and development of tumorigenesis. Thus, the aim of the current study was to investigate the immunoregulatory role of Notch signaling pathway to peripheral and tumor-infiltrating CD8+ T cells in patients with colorectal carcinoma. A total of 46 patients with colorectal carcinoma and 20 health individuals were enrolled, and CD8+ T cells were purified from both peripheral bloods and carcinoma specimens. Cytolytic and noncytolytic functions of CD8+ T cells in response to Notch signaling inhibition were evaluated by measurements of lactate dehydrogenase release and proinflammatory cytokines production in both direct and indirect contact co-culture system to target HT29 cells. Cellular proliferation and inhibitory receptors expression in CD8+ T cells were also assessed by CCK-8 method and flow cytometry. There was no remarkable difference in percentage of CD8+ T cells between healthy individuals and patients with colorectal carcinoma. Notch1/2 and Hes1/5 mRNAs were elevated expressed in tumor-infiltrating CD8+ T cells in patients with colorectal carcinoma, however, did not correlated with tumor differentiation or stages. CD8+ T cells from healthy individuals presented stronger cytotoxicity, which was not affected by Notch signaling inhibitor. Inhibition of Notch signaling pathway not only promoted cytotoxicity of tumor-infiltrating CD8+ T cells, but also enhanced proinflammatory cytokines (including IFN-γ, TNF-α, IL-1β, IL-6, and IL-8) production by CD8+ T cells from patients with colorectal carcinoma. This process was accompanied by decreased expression of PD-1 in CD8+ T cells without influencing cellular proliferation. Our results indicated a potential immunosuppressive property of Notch signaling pathway, which dampened both cytolytic and noncytolytic functions of CD8+ T cells probably via induction of PD-1 in patients with colorectal carcinoma.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CD8(+) T cells; Colorectal carcinoma; Notch signaling

Mesh:

Substances:

Year:  2017        PMID: 29096354     DOI: 10.1016/j.biopha.2017.10.143

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

Review 1.  Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling.

Authors:  Shin-Ichi Tsukumo; Koji Yasutomo
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

Review 2.  Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives.

Authors:  Gillian Moore; Stephanie Annett; Lana McClements; Tracy Robson
Journal:  Cells       Date:  2020-06-20       Impact factor: 6.600

3.  miR‑3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2.

Authors:  Daqing Yang; Rizeng Li; Jianfu Xia; Wencai Li; Hong Zhou
Journal:  Mol Med Rep       Date:  2018-10-09       Impact factor: 2.952

4.  Interleukin-35 Dampens CD8+ T Cells Activity in Patients With Non-viral Hepatitis-Related Hepatocellular Carcinoma.

Authors:  Lanlan Yang; Xue Shao; Shengnan Jia; Qian Zhang; Zhenjing Jin
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

5.  Interleukin-24 Regulates T Cell Activity in Patients With Colorectal Adenocarcinoma.

Authors:  Yang Zhang; Ye Liu; Yuechao Xu
Journal:  Front Oncol       Date:  2019-12-10       Impact factor: 6.244

6.  Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.

Authors:  Shenglan Huang; Jian Zhang; Xiaolan Lai; Lingling Zhuang; Jianbing Wu
Journal:  Front Mol Biosci       Date:  2021-12-24

7.  Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8+ T cell cytotoxicity in patients with gastric cancer.

Authors:  Junli Xu; Rongya Guo; Jing Jia; Yun He; Shuixiang He
Journal:  BMC Immunol       Date:  2021-10-07       Impact factor: 3.615

8.  Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer.

Authors:  Chin-King Looi; Li-Lian Gan; Wynne Sim; Ling-Wei Hii; Felicia Fei-Lei Chung; Chee-Onn Leong; Wei-Meng Lim; Chun-Wai Mai
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

9.  Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.

Authors:  Geoffrey L Uy; Ibrahim Aldoss; Matthew C Foster; Peter H Sayre; Matthew J Wieduwilt; Anjali S Advani; John E Godwin; Martha L Arellano; Kendra L Sweet; Ashkan Emadi; Farhad Ravandi; Harry P Erba; Michael Byrne; Laura Michaelis; Max S Topp; Norbert Vey; Fabio Ciceri; Matteo Giovanni Carrabba; Stefania Paolini; Gerwin A Huls; Mojca Jongen-Lavrencic; Martin Wermke; Patrice Chevallier; Emmanuel Gyan; Christian Récher; Patrick J Stiff; Kristen M Pettit; Bob Löwenberg; Sarah E Church; Erica Anderson; Jayakumar Vadakekolathu; Marianne Santaguida; Michael P Rettig; John Muth; Teia Curtis; Erin Fehr; Kuo Guo; Jian Zhao; Ouiam Bakkacha; Kenneth Jacobs; Kathy Tran; Patrick Kaminker; Maya Kostova; Ezio Bonvini; Roland B Walter; Jan K Davidson-Moncada; Sergio Rutella; John F DiPersio
Journal:  Blood       Date:  2021-02-11       Impact factor: 25.476

Review 10.  Notch signaling pathway: architecture, disease, and therapeutics.

Authors:  Binghan Zhou; Wanling Lin; Yaling Long; Yunkai Yang; Huan Zhang; Kongming Wu; Qian Chu
Journal:  Signal Transduct Target Ther       Date:  2022-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.